1 year return (CAGR)
-34.11%
Acarix A/S Exchange (ST, SEK)
ACARIX.ST
0.19
+0.00 (+0.31%)
HealthcareMedical Devices
Loading...
3 year return (CAGR)
-4.00%
5 year return (CAGR)
-27.47%
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
238.67M
Price/Sales
25.88
Ent value
213.75M
Price/Book
5.45
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-36.85%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.19 |
| Daily high | 0.19 |
| Daily low | 0.19 |
| Daily Volume | 1.06M |
| All-time high | 8.29 |
| 1y analyst estimate | 0.40 |
| Beta | -0.21 |
| EPS (TTM) | -0.03 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ACARIX.ST | S&P500 | |
| Current price drop from All-time high | -97.68% | -0.77% |
| Highest price drop | -97.86% | -56.47% |
| Date of highest drop | 21 Dec 2023 | 9 Mar 2009 |
| Avg drop from high | -82.17% | -10.65% |
| Avg time to new high | 413 days | 12 days |
| Max time to new high | 2472 days | 1805 days |
News
Acarix AB (ACIXF) reports robust Q2 2026 results with US revenue up 223%, UAE market entry, and key progress toward CPT1 reimbursement transition.
August 16, 2026
Acarix has secured regulatory approval for its CADScor system in the UAE, a step that paves the way for the device's commercial availability.
August 11, 2026
Acarix AB (publ) today announced the publication of a peer-reviewed study in PLOS Digital Health showing that the seismocardiography (SCG) technology at the heart of its CE-marked, FDA-cleared CADScor...
September 11, 2026
As European markets navigate the complexities of geopolitical tensions and inflationary pressures, investors are increasingly exploring diverse opportunities across various sectors. Penny stocks, a te...
May 21, 2026
Acarix AB (publ) today announced that the CADScor® System has received regulatory approval from the Emirates Drug Establishment (EDE) and the Ministry of Health and Prevention (MOHAP), clearing the wa...
August 10, 2026
European markets have experienced volatility recently, with the pan-European STOXX Europe 600 Index reaching a new high but ending the week nearly flat. As investors navigate these fluctuations, penny...
February 17, 2026
Acarix today announced its CADScor®System has successfully achieved certification under the European Union Medical Device Regulation (EU MDR 2017/745).
February 4, 2026
As December 2025 unfolds, the European markets are showing a mix of cautious optimism and strategic anticipation, with the pan-European STOXX Europe 600 Index posting modest gains amid hopes for inter...
December 12, 2025
As the European market navigates a mixed landscape with major stock indexes showing varied performance, investors are keeping a close eye on opportunities that may arise from current economic conditio...
November 4, 2025